Bank of New Hampshire’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Bank of New Hampshire's PFE Position: Q2 2026 in Review
Bank of New Hampshire sold out of Pfizer (PFE) in Q2 2026, closing a stake of 326 shares — an estimated $9.15K sold.
Bank of New Hampshire first reported a position in PFE in Q2 2021 and held it in 20 quarters. The position peaked at $931K in Q4 2021. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bank of New Hampshire reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Bank of New Hampshire sold 326 Pfizer shares in Q2 2026, an estimated $9.15K.
- Bank of New Hampshire first reported a position in Pfizer in Q2 2021 and held it in 20 quarters.
- Bank of New Hampshire's Pfizer position peaked at $931K in Q4 2021.
- 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.